TEVA FY 2010 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16.1B+16.0% YoY

Gross Profit

$9.1B56.2% margin

Operating Income

$3.9B24.0% margin

Net Income

$3.3B20.7% margin

EPS (Diluted)

$3.67

Cash Flow

Operating Cash Flow

$4.1B

Free Cash Flow

$3.4B

Stock-Based Comp.

$80M

Balance Sheet

Total Assets

$39.1B

Total Liabilities

$17.1B

Stockholders' Equity

$21.9B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.1B	$13.9B	+16.0%
Gross Profit	$9.1B	$7.4B	+23.0%
Operating Income	$3.9B	$2.4B	+61.0%
Net Income	$3.3B	$2.0B	+66.5%